Grape King BioTPE:1707 -0.11%78 Interest Coverage is 638.67 as of Dec. 2025, which is 107% above its 10-year median of 308.76. GuruFocus rates TPE:1707 with a GF Score™ of 78/100 and a GF Value™ of NT$144.03 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 685 Drug Manufacturers companies, Grape King Bio ranks better than 90.36% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Grape King Bio's
Operating Income
for the
three
months ended in Dec. 2025 was NT$743 Mil. Grape King Bio's Interest Expense for the
three
months ended in Dec. 2025 was NT$-1 Mil.
Grape King Bio's interest coverage for the quarter that ended in Dec. 2025 was 638.67.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Grape King Bio Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Grape King Bio's Interest Coverage or its related term are showing as below:
TPE:1707'
s Interest Coverage Range Over the Past 10 Years
Min: 70.46 Med: 308.76 Max: 1078.51
Current: 451.02
TPE:1707's Interest Coverage is ranked better than 90.36% of 685
companies
in the Drug Manufacturers industry
Industry Median: 12.75
vs TPE:1707: 451.02
Grape King Bio (TPE:1707) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Grape King Bio Interest Coverage Related Terms
Grape King Bio Interest Coverage Historical Data
* Premium members only.
The historical data trend for Grape King Bio's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
TPE:1707 vs ZTS, UTHR: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Grape King Bio's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Grape King Bio Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Grape King Bio's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Grape King Bio's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Grape King Bio (TPE:1707) has a Interest Coverage of 638.67 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Grape King Bio and its competitors. This is 107% above median its historical median of 308.76. Over the past decade, Grape King Bio's Interest Coverage has ranged from 70.46 to 1,078.51. According to the industry distribution chart, Grape King Bio ranks #66 out of 685 companies in the Drug Manufacturers industry, placing it in the top 9.6%.
Is Grape King Bio's Interest Coverage too high?
Grape King Bio's current Interest Coverage of 638.67 is 107% above median its 10-year median of 308.76. Over the past 10 years, this metric has ranged from a low of 70.46 to a high of 1,078.51. The Drug Manufacturers industry median Interest Coverage is 12.75. Grape King Bio's value of 638.67 is 4909.2% above this industry median. Based on the distribution chart, Grape King Bio ranks #66 out of 685 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Grape King Bio has a GF Score™ of 78/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Grape King Bio's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Grape King Bio ranks #66 out of 685 companies for Interest Coverage. This places Grape King Bio in the top 10% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 12.75. Grape King Bio's value of 638.67 is 4909.2% above this benchmark. Historically, Grape King Bio's own Interest Coverage has ranged from 70.46 to 1,078.51 over the past decade. While the company's 10-year median is 308.76 vs. the industry median of 12.75, Grape King Bio has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.75, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grape King Bio's current Interest Coverage of 638.67 is 4909.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Grape King Bio and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grape King Bio's current Interest Coverage is 638.67, which is 107% above median its own 10-year median of 308.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grape King Bio stock overvalued right now?
Based on GuruFocus' analysis, Grape King Bio (TPE:1707) is currently considered Possible Value Trap. The stock's GF Value™ is NT$144.03, compared to a current price of NT$91.00 — trading 36.8% below its estimated fair value. The current Interest Coverage is 638.67, which is 107% above median its 10-year median of 308.76 and 4909.2% above the Drug Manufacturers industry median of 12.75. Grape King Bio's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Grape King Bio (TPE:1707), the current Interest Coverage is 638.67 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Grape King Bio (TPE:1707) Overvalued in 2026?
Based on GuruFocus' analysis, Grape King Bio stock appears to be undervalued.
The current stock price of NT$91.00 is trading 36.8% below its estimated GF Value™ of NT$144.03.
GuruFocus considers Grape King Bio to be Possible Value Trap.
Key valuation signals for TPE:1707:
Interest Coverage: 638.67 (107% above median its 10-year median of 308.76)
GF Value™: NT$144.03 vs. price of NT$91.00 (36.8% below fair value)
Industry Position: 4909.2% above the Drug Manufacturers median (#66 of 685)
No single metric tells the full story. See the TPE:1707 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in producing and selling pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food. The company has three segments: MLM (Multi-Level Marketing), which is a direct seller of Pro-partner Inc, including the company's development and manufacturing products for Pro-partner Inc, the Distributors segment includes the company's self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others, and it derives a majority of its revenue from Taiwan.
78GF Score
Get the complete analysis for TPE:1707
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1707 has been successfully added to your 
